WO2003045546A1 - The use of metal-chelating adsorbents - Google Patents
The use of metal-chelating adsorbents Download PDFInfo
- Publication number
- WO2003045546A1 WO2003045546A1 PCT/GB2002/005326 GB0205326W WO03045546A1 WO 2003045546 A1 WO2003045546 A1 WO 2003045546A1 GB 0205326 W GB0205326 W GB 0205326W WO 03045546 A1 WO03045546 A1 WO 03045546A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chamber
- radiation
- metal
- shroud
- water
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
- A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/1785—Syringes comprising radioactive shield means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/223—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material containing metals, e.g. organo-metallic compounds, coordination complexes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
- B01J20/289—Phases chemically bonded to a substrate, e.g. to silica or to polymers bonded via a spacer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/3092—Packing of a container, e.g. packing a cartridge or column
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3206—Organic carriers, supports or substrates
- B01J20/3208—Polymeric carriers, supports or substrates
- B01J20/321—Polymeric carriers, supports or substrates consisting of a polymer obtained by reactions involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3206—Organic carriers, supports or substrates
- B01J20/3208—Polymeric carriers, supports or substrates
- B01J20/3212—Polymeric carriers, supports or substrates consisting of a polymer obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3214—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the method for obtaining this coating or impregnating
- B01J20/3217—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond
- B01J20/3219—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond involving a particular spacer or linking group, e.g. for attaching an active group
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3244—Non-macromolecular compounds
- B01J20/3246—Non-macromolecular compounds having a well defined chemical structure
- B01J20/3248—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such
- B01J20/3255—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such comprising a cyclic structure containing at least one of the heteroatoms nitrogen, oxygen or sulfur, e.g. heterocyclic or heteroaromatic structures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3244—Non-macromolecular compounds
- B01J20/3265—Non-macromolecular compounds with an organic functional group containing a metal, e.g. a metal affinity ligand
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/34—Regenerating or reactivating
- B01J20/3425—Regenerating or reactivating of sorbents or filter aids comprising organic materials
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/34—Regenerating or reactivating
- B01J20/345—Regenerating or reactivating using a particular desorbing compound or mixture
- B01J20/3475—Regenerating or reactivating using a particular desorbing compound or mixture in the liquid phase
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J45/00—Ion-exchange in which a complex or a chelate is formed; Use of material as complex or chelate forming ion-exchangers; Treatment of material for improving the complex or chelate forming ion-exchange properties
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21F—PROTECTION AGAINST X-RADIATION, GAMMA RADIATION, CORPUSCULAR RADIATION OR PARTICLE BOMBARDMENT; TREATING RADIOACTIVELY CONTAMINATED MATERIAL; DECONTAMINATION ARRANGEMENTS THEREFOR
- G21F5/00—Transportable or portable shielded containers
- G21F5/015—Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation units; Radioisotope containers
- G21F5/018—Syringe shields or holders
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/54—Sorbents specially adapted for analytical or investigative chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/62—In a cartridge
Definitions
- This invention relates to the use of metal-chelating adsorbents for the removal of contaminant metal ions from diagnostic and therapeutic formulations.
- Radio-immunotherapy relies on the targeted delivery of conjugates of monoclonal antibodies with radioactive metal ions to specific tumour sites, the specificity being a function of the antibody chosen.
- the active agent is prepared by incubating a metal chelate-antibody conjugate with an excess of the radio-isotopic metal ion for 0.5 - 1.0 hr. This is often followed by a series of time-consuming purification procedures to remove unbound or non-specifically bound metal ions.
- Typical purification protocols include dialysis and combinations of ion-exchange chromatography and gel filtration chromatography. Lengthy purification procedures lead to significant decreases in effective doses of radiation, particularly for conjugates comprising nuclides with short half-lives. Additionally, multi-step purification procedures lead to undesirable dilution effects.
- a metal ion-chelating adsorbent or another suitable material is used to capture radiactive metal ions in a liquid sample.
- a method comprises using a syringe mounted at the outlet of a chamber to draw the sample through the chamber, wherein the chamber is housed within a radiation-absorbing shroud and contains an adsorbent for the component, and wherein the chamber also has an inlet and means for mounting a syringe thereon.
- the component to be removed may be a radio-labelled antibody or other biological material. Passing the liquid sample through the chamber by use of negative pressure or vacuum, rather than using positive pressure, is an important safety feature of the invention, and reduces the risk of leakage/atomisation of radioactive materials.
- This invention provides an expeditious procedure for the removal of contaminant metal ions from pharmaceutical and other therapeuticformulations, e.g. utilising a terminally sterilized single-use disposable cartridge or element.
- a terminally sterilized single-use disposable cartridge or element e.g. utilising a terminally sterilized single-use disposable cartridge or element.
- the invention utilises a device housing incorporating a syringe mounted at the outlet of a chamber to draw the sample through the chamber, wherein the chamber is housed within a radiation-absorbing shroud and contains an adsorbent for the said component, and wherein the chamber also has an inlet and means for mounting a syringe thereon.
- the device chamber is packed with a metal ion-chelating adsorbent capable of capturing radioactive metal ions from aqueous solutions with high efficiency.
- the metal ion-chelating adsorbent comprises diethylenetriaminetetraacetic acid groups attached to a fluorocarbon matrix by means of a linking chemistry devoid of ester or amide bonds.
- the device is used to remove contaminating metal ions from pharmaceutical preparations, including radio-labelled antibody conjugates, by drawing solutions of such pharmaceutical preparations through the packed chamber.
- the liquid sample is held in a vial contained within a radiation- adsorbing shroud which engages with the radiation-adsorbing shroud enclosing the chamber, to provide a continuous shield.
- the syringe mounted at the chamber outlet is contained within a radiation-adsorbing shroud which engages with the radiation-adsorbing shroud enclosing the chamber, to provide a continuous shield.
- Another preference is that all wetted parts are rendered sterile before use.
- FIG. 1 shows a chamber 1 having a syringe needle 2 mounted at its inlet, connected via a Luer fitting 3, and a seal 4.
- the combination is adapted to receive liquid sample 5 in a container 6.
- the chamber also has a syringe 7 mounted at its outlet and connected via a Luer fitting 8.
- the chamber includes an adsorbent 9.
- the combination of these components is surrounded by a radiation-absorbing shroud 10. In use, raising the syringe piston 11 draws liquid through the adsorbent 9. The syringe 7, containing less contaminated liquid, can then be removed.
- Fig.2 is a cross-sectional view of a device attached to a single vial holder, whilst Fig. 3 shows a multi-vial holder.
- the significance of this is that there are different designs of radio-labelling vial which are of different heights and widths. Consequently, it may be advantageous if the device is used in conjunction with a holder capable of holding multiple vials of different types, as well as single vials.
- Fig. 2 shows many of the same components, and uses the same reference numerals for them, as Fig. 1.
- the syringe needle 2 is optionally vented to allow pressure equilibration in vial.
- the vial 6 is preferably of glass.
- the adsorbent 9 may be any adsorbent packing material capable of binding and separating free radio-label from a (non-bound) radio-labelled biological molecule or compound.
- Fig. 2 shows a filter 12 and, for guidance only, dimensions (each including a decimal point).
- the ligand comprises coordination groups selected from COOH, P0 3 H and S0 3 H
- the ligand backbone is linked, optionally by means of a spacer, to a support matrix
- the ligand backbone/spacer is free of ester and amide bonds.
- Such a conjugate can be used for the capture of metal ions from water, aqueous solutions, blood, plasma, and pharmaceutical and therapeutic products and proteins.
- Metal-chelating ligand-matrix conjugates suitable for use in the present invention can be represented by formula (1)
- A represents a C ⁇ saturated hydrocarbon chain; each X is COOH, PO 3 H or S0 3 H; n is 2 or more;
- M is an optional spacer arm; and Z is a support matrix.
- A may be linear or branched alkylene such as divalent methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl or tert- butyl.
- X is preferably COOH.
- n is preferably 2, so that the conjugate has 4 coordination groups, and usually no more than 3, 4 or 5.
- the support matrix may be any compound or material, particulate or non- particulate, porous or non-porous, which may be used for the immobilization of metal-chelating ligands, to form a metal-chelating ligand-matrix conjugate, thereby providing a convenient means of binding metal ions from solution.
- particulate support matrices include natural polymers such as agarose, dextran, cellulose or starch, synthetic polymers and co-polymers such as perfluorocarbons, polystyrene, polyacrylamide, polyvinyl alcohol and polymethyl methacrylate, and inorganic compounds such as silica, glass, alumina and metal oxides.
- fluorocarbon materials such as PTFE as a chromatographic support in this invention has specific advantages over other commercially available support matrices, including chemical and biological inertness, compatibility with gamma-irradiation and minimal swelling upon wetting which minimizes any sample dilution effects during use.
- the support matrix may be in the form of particles, membranes or sheets comprising such polymers.
- Covalent attachment of ligand structures as represented by formula (1 ) to the support matrix Z may be achieved by use of a variety of activation agents including, but not limited to, cyanogen bromide, epichlorohydrin, 1 ,4-butanediol diglycidyl ether, tosyl chloride, tresyl chloride, and cyanuric chloride.
- the spacer group M may be absent, although it will be understood by those skilled in the art that the non-functional part of any functional groups used to conjugate Z and the coordination groups may be present in the product. If present, M may be any group which is conveniently capable of holding the ligand at a distance from the support matrix.
- spacer groups include diaminoalkanes and polyvinyl alcohol (PVA).
- a preferred spacer M comprises a group of the formula -T-L- wherein T is O, S or NR, R is H or C,_ 6 alkyl, and L is an optionally substituted
- Conjugates represented by formula (1) can readily be prepared with a stable C-N bond formed between the ligand and the support matrix Z.
- a variety of methods is available, which avoid introducing an ester or amide bond.
- the method comprises the reaction of a polyamine of the formula H-[NH-A] n -NH 2 , with an activated support matrix Z-Y, wherein Y is a reactive group, optionally in the presence of or after reaction of either component with a compound introducing M; and reaction of the product with a compound of the formula Q-CH 2 -X, wherein Q is a group reactive with NH.
- a diamine such as diethylenetriamine is coupled to an activated support matrix foil owed by reaction with a halogenoacetic acid such as bromoacetic acid or chloroacetic acid to give a conjugate by the method shown in the following scheme:
- a desirable feature of preferred metal-chelating ligand-matrix conjugates for use according to this invention is the ultrastable C-N linkage between the support matrix and the metal-chelating ligand, thereby enabling the use of such conjugates for sequestering metal ions at extremes of pH, ionic strength and temperature, without the risk of potentially toxic metal ion leachates.
- Such chemistries allow sterilisation of the adsorbent by sterilisation techniques such as gamma irradiation.
- the conjugate may be reused, if necessary or desired, following cleaning and sanitisation with, for example, solutions of nitric acid and sodium hydroxide.
- An aspect of this invention is a one-step chromatographic method for the removal of contaminant metal ions from diagnostic and therapeutic products.
- unbound and/or loosely bound metal ions are scavenged from a pharmaceutical product by passing the preparation through a terminally sterilized column containing a conjugate represented by formula (1 ).
- Such adsorbents have a high affinity for heavy metals, and the method yields a therapeutic product that is substantially free of unbound metal ions and is suitable for administration to humans in vivo.
- DETATA is diethylenetriaminetetraacetic acid.
- Stage 2 Preparation of diethylenetriamine-agarose Epoxy-activated Sepharose CL-6B (94g settled weight) from stage 1 was mixed with 0.2M sodium bicarbonate solution (225ml) and diethylenetriamine
- stage 2 The diethylenetriamine-agarose (stage 2) was mixed with bromoacetic acid (16g), 2M sodium hydroxide (50ml) and 1 M sodium bicarbonate (50ml). The resulting reaction mixture was adjusted to pH 7.0 with sodium hydroxide and left to react at room temperature for 16 hours. The gel was then washed with RO water (10 x 100ml portions) to remove excess reactants.
- DETATA-agarose (5g) was washed sequentially with RO water (10 x 5ml portions), 1M sodium hydroxide (10 x 5ml portions) and RO water (10 x 5ml portions). The gel was then mixed with 5ml RO water and the slurry gravity packed into a 10ml column. A solution of non-radioactive 89 yttrium chloride (2.191 mg/ml in RO water; 25ml) was loaded onto the column under gravity followed by RO water (5ml) to wash out any unbound metal ion. Elution of bound yttrium was achieved by passing 10mM hydrochloric acid (25ml) through the column. The flow-through, eluted fractions and the stock yttrium solutions were analysed for elemental yttrium by Inductively Coupled Plasma Atomic Emission Spectrometry. Results are shown in Table 1.
- the settled gel from stage 2 was suspended in 1 M sodium hydrogen carbonate (25ml) and 2M sodium hydroxide solution (25ml). Bromoacetic acid (8g) was added and the pH of the suspension adjusted to pH 7.0 by the drop- wise addition of 2M sodium hydroxide. The reaction mixture was stirred for 16 hours at room temperature. The final chelate adsorbent was washed with an excess of RO water at the end of the reaction. Copper-binding capacity
- DETATA-PTFE adsorbent (1.2g dry weight) was dry packed to a bed height of 20mm into a cartridge (40mm height x 8mm i.d.) as shown in Fig. 2, containing a luer fitting at the inlet port and a 0.45mm filter connected to a luer fitting at the outlet port.
- the packed cartridge was housed within a radiation shield to minimize exposure to radiation during use.
- the cartridge was regenerated by sequentially washing with nitric acid (0.1M, 5ml), RO water (5ml), sodium hydroxide (1M, 5ml) and finally with RO water (10ml).
- a preparation of antibody immunoconjugate labelled with 90 yttrium was prepared by incubating 90 ytt ⁇ ium chloride (37Mbq, 200 ⁇ l in 0.1M acetate buffer pH 5.5) with antibody immunoconjugate (5 ⁇ l, 30 ⁇ g) for 30 minutes.
- the radio-labelled reaction mixture was passed through the cartridge and immunoconjugate eluted with sodium acetate (3x 1ml, 0.1M pH 5.5).
- the radio- chemical purity of the conjugate prior to purification was 96% and increased to 98% after purification using the cartridge.
Landscapes
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Anesthesiology (AREA)
- Optics & Photonics (AREA)
- High Energy & Nuclear Physics (AREA)
- General Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- External Artificial Organs (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002343100A AU2002343100A1 (en) | 2001-11-27 | 2002-11-27 | The use of metal-chelating adsorbents |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBPCT/GB01/05231 | 2001-11-27 | ||
PCT/GB2001/005231 WO2002041989A1 (en) | 2000-11-27 | 2001-11-27 | Metal-chelating adsorbents and their use |
GB0212406.3 | 2002-05-29 | ||
GB0212406A GB0212406D0 (en) | 2002-05-29 | 2002-05-29 | Metal-chelating adsorbents and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003045546A1 true WO2003045546A1 (en) | 2003-06-05 |
Family
ID=26245775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2002/005326 WO2003045546A1 (en) | 2001-11-27 | 2002-11-27 | The use of metal-chelating adsorbents |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002343100A1 (en) |
WO (1) | WO2003045546A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITFI20080193A1 (en) * | 2008-10-10 | 2010-04-11 | Tema Sinergie Srl | DEVICE AND APPARATUS FOR RAPIDING FRACTION AND THE INFUSION OF RADIOPHARMACEUTICALS. |
EP2544188A3 (en) * | 2005-07-27 | 2013-08-28 | Mallinckrodt LLC | Radiation-shielding assemblies and methods of using the same |
WO2015109151A1 (en) * | 2014-01-17 | 2015-07-23 | Genzyme Corporation | Sterile chromatography resin and use thereof in manufacturing processes |
WO2015109146A1 (en) * | 2014-01-17 | 2015-07-23 | Genzyme Corporation | Sterile chromatography and manufacturing processes |
US9650412B2 (en) | 2013-03-08 | 2017-05-16 | Genzyme Corporation | Integrated continuous manufacturing of therapeutic protein drug substances |
US11369703B2 (en) | 2018-08-31 | 2022-06-28 | Genzyme Corporation | Sterile chromatography resin and use thereof in manufacturing processes |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4401108A (en) * | 1980-02-13 | 1983-08-30 | Thomas Jefferson University | Radioactive material loading, calibration and injection systems |
US4599175A (en) * | 1983-09-30 | 1986-07-08 | Asahi Kasei Kogyo Kabushiki Kaisha | Process for separating and purifying metallic elements by displacement chromatography |
EP0281368A2 (en) * | 1987-03-02 | 1988-09-07 | E.I. Du Pont De Nemours And Company | Enzyme immobilization and bioaffinity separations with perfluorocarbon polymer-based supports |
WO1991006008A1 (en) * | 1989-10-11 | 1991-05-02 | Akzo N.V. | Method for purifying chelator conjugated compounds |
WO1992017403A1 (en) * | 1991-04-05 | 1992-10-15 | Brigham Young University | Support bonded polyalkylene-polyamine-poly(carboxylic acid) and extraction of metal ions therewith |
WO1994022490A1 (en) * | 1993-03-29 | 1994-10-13 | Immunomedics, Inc. | Conjugates of proteins and bifunctional ligands |
EP0621074A1 (en) * | 1993-04-22 | 1994-10-26 | E.I. Du Pont De Nemours And Company | Hydrophilic polymer coated perfluorocarbon polymer-based matrices, their preparation and use in bioaffinity separations |
WO2002041989A1 (en) * | 2000-11-27 | 2002-05-30 | Prometic Biosciences Ltd. | Metal-chelating adsorbents and their use |
-
2002
- 2002-11-27 WO PCT/GB2002/005326 patent/WO2003045546A1/en not_active Application Discontinuation
- 2002-11-27 AU AU2002343100A patent/AU2002343100A1/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4401108A (en) * | 1980-02-13 | 1983-08-30 | Thomas Jefferson University | Radioactive material loading, calibration and injection systems |
US4599175A (en) * | 1983-09-30 | 1986-07-08 | Asahi Kasei Kogyo Kabushiki Kaisha | Process for separating and purifying metallic elements by displacement chromatography |
EP0281368A2 (en) * | 1987-03-02 | 1988-09-07 | E.I. Du Pont De Nemours And Company | Enzyme immobilization and bioaffinity separations with perfluorocarbon polymer-based supports |
WO1991006008A1 (en) * | 1989-10-11 | 1991-05-02 | Akzo N.V. | Method for purifying chelator conjugated compounds |
WO1992017403A1 (en) * | 1991-04-05 | 1992-10-15 | Brigham Young University | Support bonded polyalkylene-polyamine-poly(carboxylic acid) and extraction of metal ions therewith |
WO1994022490A1 (en) * | 1993-03-29 | 1994-10-13 | Immunomedics, Inc. | Conjugates of proteins and bifunctional ligands |
EP0621074A1 (en) * | 1993-04-22 | 1994-10-26 | E.I. Du Pont De Nemours And Company | Hydrophilic polymer coated perfluorocarbon polymer-based matrices, their preparation and use in bioaffinity separations |
WO2002041989A1 (en) * | 2000-11-27 | 2002-05-30 | Prometic Biosciences Ltd. | Metal-chelating adsorbents and their use |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2544188A3 (en) * | 2005-07-27 | 2013-08-28 | Mallinckrodt LLC | Radiation-shielding assemblies and methods of using the same |
US8633461B2 (en) | 2005-07-27 | 2014-01-21 | Mallinckrodt Llc | Radiation-shielding assemblies and methods of using the same |
EP2179758A3 (en) * | 2008-10-10 | 2010-07-07 | Tema Sinergie S.r.l. | Device and apparatus for fractionation and infusion of radioactive drugs |
ITFI20080193A1 (en) * | 2008-10-10 | 2010-04-11 | Tema Sinergie Srl | DEVICE AND APPARATUS FOR RAPIDING FRACTION AND THE INFUSION OF RADIOPHARMACEUTICALS. |
US9650412B2 (en) | 2013-03-08 | 2017-05-16 | Genzyme Corporation | Integrated continuous manufacturing of therapeutic protein drug substances |
US10711034B2 (en) | 2013-03-08 | 2020-07-14 | Genzyme Corporation | Integrated continuous manufacturing of therapeutic protein drug substances |
US9657056B2 (en) | 2013-03-08 | 2017-05-23 | Genzyme Corporation | Integrated continuous manufacturing of therapeutic protein drug substances |
US9650413B2 (en) | 2013-03-08 | 2017-05-16 | Genzyme Corporation | Integrated continuous manufacturing of therapeutic protein drug substances |
US10071364B2 (en) | 2014-01-17 | 2018-09-11 | Genzyme Corporation | Sterile affinity chromatography resin |
AU2015206341B2 (en) * | 2014-01-17 | 2019-08-22 | Genzyme Corporation | Sterile chromatography resin and use thereof in manufacturing processes |
US9630165B2 (en) | 2014-01-17 | 2017-04-25 | Genzyme Corporation | Sterile chromatography resin and use thereof in manufacturing processes |
JP2017506218A (en) * | 2014-01-17 | 2017-03-02 | ジェンザイム・コーポレーション | Aseptic chromatography and manufacturing method |
CN106068150A (en) * | 2014-01-17 | 2016-11-02 | 建新公司 | Aseptic chromatographic resin and purposes in a manufacturing process thereof |
KR20160111427A (en) * | 2014-01-17 | 2016-09-26 | 젠자임 코포레이션 | Sterile chromatography resin and use thereof in manufacturing processes |
CN106068150B (en) * | 2014-01-17 | 2018-02-27 | 建新公司 | Sterile chromatographic resin and its purposes in a manufacturing process |
CN108114508A (en) * | 2014-01-17 | 2018-06-05 | 建新公司 | Sterile chromatographic resin and its purposes in a manufacturing process |
WO2015109146A1 (en) * | 2014-01-17 | 2015-07-23 | Genzyme Corporation | Sterile chromatography and manufacturing processes |
US10087214B2 (en) | 2014-01-17 | 2018-10-02 | Genzyme Corporation | Sterile chromatography and manufacturing processes |
RU2679134C2 (en) * | 2014-01-17 | 2019-02-06 | Джензим Корпорейшн | Sterile chromatography resin and use thereof in manufacturing processes |
JP2017508135A (en) * | 2014-01-17 | 2017-03-23 | ジェンザイム・コーポレーション | Aseptic chromatography resins and their use in manufacturing processes |
AU2015206422B2 (en) * | 2014-01-17 | 2020-05-21 | Genzyme Corporation | Sterile chromatography and manufacturing processes |
WO2015109151A1 (en) * | 2014-01-17 | 2015-07-23 | Genzyme Corporation | Sterile chromatography resin and use thereof in manufacturing processes |
JP2020121995A (en) * | 2014-01-17 | 2020-08-13 | ジェンザイム・コーポレーション | Sterile chromatography and manufacturing processes |
CN108114508B (en) * | 2014-01-17 | 2020-10-27 | 建新公司 | Sterile chromatography resin and use thereof in manufacturing process |
TWI709569B (en) * | 2014-01-17 | 2020-11-11 | 美商健臻公司 | Sterile chromatography resin and use thereof in manufacturing processes |
US10919021B2 (en) | 2014-01-17 | 2021-02-16 | Genzyme Corporation | Sterile chromatography resin and use thereof in manufacturing processes |
KR102306419B1 (en) * | 2014-01-17 | 2021-09-30 | 젠자임 코포레이션 | Sterile chromatography resin and use thereof in manufacturing processes |
AU2019268188B2 (en) * | 2014-01-17 | 2022-03-17 | Genzyme Corporation | Sterile chromatography resin and use thereof in manufacturing processes |
JP7055161B2 (en) | 2014-01-17 | 2022-04-15 | ジェンザイム・コーポレーション | Aseptic chromatography and manufacturing method |
US11912739B2 (en) | 2014-01-17 | 2024-02-27 | Genzyme Corporation | Sterile chromatography and manufacturing processes |
US11839861B2 (en) | 2014-01-17 | 2023-12-12 | Genzyme Corporation | Sterile chromatography resin and use thereof in manufacturing processes |
US11369703B2 (en) | 2018-08-31 | 2022-06-28 | Genzyme Corporation | Sterile chromatography resin and use thereof in manufacturing processes |
Also Published As
Publication number | Publication date |
---|---|
AU2002343100A1 (en) | 2003-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0237659B1 (en) | Process for the production of protein a-silica immunoadsorbent | |
US7326182B2 (en) | Method of using device for bio-affinity material for treatment of blood or plasma | |
JP5026648B2 (en) | Method and equipment for removal of metal cations from liquids by polyazacycloalkane resins grafted on a support | |
EP0247592B1 (en) | Adsorbent for beta2-microglobulin and immunoglobulin l-chain | |
US6686457B1 (en) | Material | |
JPH0144725B2 (en) | ||
WO2003045546A1 (en) | The use of metal-chelating adsorbents | |
WO2002041989A1 (en) | Metal-chelating adsorbents and their use | |
JPH022809B2 (en) | ||
CN100493695C (en) | Endotoxin adsorption material for curing endotoxemia | |
CN101069751B (en) | Protein A immuo adsorption material and preparing method | |
JP2928589B2 (en) | Adsorbent for modified LDL and apparatus for removing modified LDL using the same | |
US20040022784A1 (en) | Oligosaccharide supports for e.g. removal of antibodies from blood | |
CN102671638A (en) | Bionic specific immunity adsorbing material and preparation method as well as application thereof | |
JP2005525874A (en) | Endotoxin binding ligands and uses thereof | |
WO1992011039A1 (en) | Derivatized tris-catechol chelating agents | |
CA2527054A1 (en) | Methods and apparatus for continuous large-scale radiolabeling of proteins | |
JP3515802B2 (en) | Hydrophobic adsorbent for lipoprotein adsorption | |
JPS63197462A (en) | Anti-human igm immune adsorbent and its production | |
Esteves et al. | New silica-immobilized hydroxypyrimidinone as sorbent of hard metal ions from aqueous fluids | |
JPS6399875A (en) | Beta 2-microglobulin adsorbing body for treatment of extracorphoreal circulation | |
JPS6187640A (en) | Separation process | |
JPH0516901B2 (en) | ||
JP2991721B2 (en) | Anti-thyroid stimulating hormone receptor antibody adsorbent and anti-thyroid stimulating hormone receptor antibody removing device using the same | |
EP0575531A1 (en) | Method of improving the elution yield of a radioisotope generator |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |